Carregant...
The New ELN Recommendations for Treating CML
After normal survival has been achieved in most patients with chronic myeloid leukemia (CML), a new goal for treating CML is survival at good quality of life, with treatment discontinuation in sustained deep molecular response (DMR; MR(4) or deeper) and treatment-free remission (TFR). Four tyrosine...
Guardat en:
| Publicat a: | J Clin Med |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7697560/ https://ncbi.nlm.nih.gov/pubmed/33207600 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9113671 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|